{"transactions":[{"id":731800,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:06:40.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":66350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":66350,"derivative":{"exercise_price":2.48,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":66350},"source":{"system":"sec-edgar","filing":"0001610717-26-000240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000161071726000240/form4.xml","form_type":"4"}},{"id":1001761,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-12T21:31:29.000Z","date":"2025-11-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":1.8473,"value":92365.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $1.7550 to $1.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired under the issuer's Employee Stock Purchase Plan on May 10, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the issuer's Employee Stock Purchase Plan on November 10, 2025."}],"balance_after":727053,"source":{"system":"sec-edgar","filing":"0001610717-25-000374","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000161071725000374/form4.xml","form_type":"4"}},{"id":1278542,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:15:52.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":532500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":532500,"derivative":{"exercise_price":4.37,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":532500},"source":{"system":"sec-edgar","filing":"0000905148-25-000438","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000438/form4.xml","form_type":"4"}},{"id":1278541,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-08T01:15:52.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":88750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired under the issuer's Employee Stock Purchase Plan on May 10, 2024."}],"balance_after":673053,"source":{"system":"sec-edgar","filing":"0000905148-25-000438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000438/form4.xml","form_type":"4"}},{"id":1696223,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T02:23:40.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":860500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 1/3rd of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/36th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":860500,"derivative":{"exercise_price":3.05,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":860500},"source":{"system":"sec-edgar","filing":"0000905148-24-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000029/form4.xml","form_type":"4"}},{"id":1696222,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-03T02:23:40.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":143425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":582303,"source":{"system":"sec-edgar","filing":"0000905148-24-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824000029/form4.xml","form_type":"4"}},{"id":1782778,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-12T20:06:37.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":58479,"price":1.7263,"value":100952.2977,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $1.71 to $1.73, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote."}],"balance_after":438878,"source":{"system":"sec-edgar","filing":"0000905148-23-000900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514823000900/form4.xml","form_type":"4"}},{"id":1960732,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-10T02:15:29.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":26987,"price":4.5552,"value":122931.1824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSUs of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average of all shares sold to cover taxes upon vesting of PSUs on March 8, 2023 for certain employees of the Issuer."}],"balance_after":380399,"source":{"system":"sec-edgar","filing":"0001567619-23-004772","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004772/doc1.xml","form_type":"4"}},{"id":1960731,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-10T02:15:29.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":28088,"price":4.6027,"value":129280.6376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSUs of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average of all shares sold to cover taxes upon vesting of PSUs on March 8, 2023 for certain employees of the Issuer."}],"balance_after":407386,"source":{"system":"sec-edgar","filing":"0001567619-23-004772","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004772/doc1.xml","form_type":"4"}},{"id":1960730,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-10T02:15:29.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":289000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards (\"PSUs\") initially granted on November 8, 2022 that were subject a performance-based vesting condition. The vesting condition was determined to be 85% satisfied on February 8, 2023. The PSUs will vest fully on March 5, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date."}],"balance_after":435474,"source":{"system":"sec-edgar","filing":"0001567619-23-004772","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923004772/doc1.xml","form_type":"4"}},{"id":2003126,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-22T01:26:50.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":337500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable with respect to 25% of the shares subject thereto on February 21, 2024, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 21, 2027, in each case, subject to continued service through the applicable vesting date."}],"balance_after":337500,"derivative":{"exercise_price":5.44,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":337500},"source":{"system":"sec-edgar","filing":"0001567619-23-003441","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923003441/doc1.xml","form_type":"4"}},{"id":2003125,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-22T01:26:50.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\") vest 1/3 annually from February 21, 2023 such that the RSUs will be fully vested on February 21, 2026. Each RSU represents a contingent right to receive one share of Codexis common stock."}],"balance_after":146474,"source":{"system":"sec-edgar","filing":"0001567619-23-003441","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761923003441/doc1.xml","form_type":"4"}},{"id":2195431,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-03T22:25:54.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject thereto on August 1, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on August 1, 2026."}],"balance_after":700000,"derivative":{"exercise_price":6.73,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001567619-22-014899","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761922014899/doc1.xml","form_type":"4"}},{"id":2216971,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:35:51.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":31.54,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-22-040252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040252/doc4.xml","form_type":"4"}},{"id":2216970,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:35:51.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 25% of the total shares subject to the option on March 15, 2022, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 15, 2025, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.73,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001209191-22-040252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040252/doc4.xml","form_type":"4"}},{"id":2216969,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:35:51.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 12, 2020, the Reporting Person was granted an option to purchase 260,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria."}],"balance_after":0,"derivative":{"exercise_price":12.15,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001209191-22-040252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040252/doc4.xml","form_type":"4"}},{"id":2216968,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:35:51.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the total shares on June 1, 2021, and then the remaining shares vest in equal monthly installments over the following 36 months, with 100% of the total shares vested on June 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.03,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0001209191-22-040252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040252/doc4.xml","form_type":"4"}},{"id":2216967,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-01T16:35:51.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":55,"value":275000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-040252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040252/doc4.xml","form_type":"4"}},{"id":2227405,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T16:10:37.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 12, 2020, the Reporting Person was granted an option to purchase 260,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 65,000 shares."}],"balance_after":65000,"derivative":{"exercise_price":12.15,"exercise_date":"2022-06-17","expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-037833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122037833/doc4.xml","form_type":"4"}},{"id":2229705,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:14:45.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":11273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":33974,"source":{"system":"sec-edgar","filing":"0001567619-22-012978","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761922012978/doc1.xml","form_type":"4"}},{"id":2335224,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T16:50:03.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly\nthereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on\neach vesting date."}],"balance_after":165000,"derivative":{"exercise_price":31.54,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-22-018495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122018495/doc4.xml","form_type":"4"}},{"id":2422351,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T18:32:31.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 12, 2020, the Reporting Person was granted an option to purchase 260,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 65,000 shares."}],"balance_after":65000,"derivative":{"exercise_price":12.15,"exercise_date":"2022-01-28","expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-005481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122005481/doc4.xml","form_type":"4"}},{"id":2663210,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:20:42.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":22701,"source":{"system":"sec-edgar","filing":"0001567619-21-012328","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761921012328/doc1.xml","form_type":"4"}},{"id":2702818,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-05-20T18:59:53.000Z","date":"2021-05-19","kind":"purchase","acquired":true,"shares":5000,"price":17.83,"value":89150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $17.78 to $17.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-21-034601","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121034601/doc4.xml","form_type":"4"}},{"id":2781666,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T21:13:07.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares subject to the option on March 15, 2022, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 15, 2025, subject to Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":92000,"derivative":{"exercise_price":16.73,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001209191-21-021617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121021617/doc4.xml","form_type":"4"}},{"id":3105200,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:09:39.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":17905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock. The restricted stock vests as to 1/3 of the shares on June 16, 2021, another 1/3 of the shares on June 16, 2022 and the final 1/3 of the shares on June 16, 2023."}],"balance_after":17905,"source":{"system":"sec-edgar","filing":"0001567619-20-012365","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000156761920012365/doc1.xml","form_type":"4"}},{"id":3125282,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T20:27:37.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended."}],"balance_after":20000,"derivative":{"exercise_price":10.46,"expiration_date":"2030-05-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-034015","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120034015/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-20"}},{"id":3125281,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:27:37.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")), through such date and subject to acceleration as provided in the 2018 EIP, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4/A is being filed solely to correct the stated grant amounts which were erroneously reported on Form 4 filed on behalf of the Reporting Person on May 20, 2020.  Pursuant to the 2018 EIP, as amended, and the Automatic Grant Program for Non-Employee Directors thereunder, the annual grant amounts increased effective with the approval of the 2018 EIP, as amended, by the stockholders of the Issuer on May 18, 2020.  Such previously filed Form 4 incorrectly stated grant amounts pursuant to the Automatic Grant Program for Non-Employee Directors prior to such amendment and restatement of the 2018 Equity Incentive Plan."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-20-034015","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120034015/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-20"}},{"id":3126705,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T16:26:16.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total shares on June 1, 2021, and then the remaining shares vest in equal monthly installments over the following 36 months, with 100% of the total shares vested on June 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":520000,"derivative":{"exercise_price":14.03,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0001209191-20-033528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919120033528/doc4.xml","form_type":"4"}},{"id":3141416,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T21:14:40.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer. The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":10.46,"expiration_date":"2030-05-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-030948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120030948/doc4.xml","form_type":"4"}},{"id":3141415,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T21:14:40.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the earlier of (x) May 18, 2021 (the first anniversary of the date of grant) or (y) the day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-20-030948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120030948/doc4.xml","form_type":"4"}},{"id":3199759,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-03-20T21:00:12.000Z","date":"2020-03-19","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was immediately exercisable for all option shares, but shares purchased under the option were subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vested in monthly installments upon completion of each month of Board service over a three year period measured from the date of grant."}],"balance_after":0,"derivative":{"exercise_price":5.42,"expiration_date":"2020-03-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-020483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/doc4.xml","form_type":"4"}},{"id":3199758,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-20T21:00:12.000Z","date":"2020-03-19","kind":"sale","acquired":false,"shares":35000,"price":6,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $6.00 to $6.02 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-020483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/doc4.xml","form_type":"4"}},{"id":3199757,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-20T21:00:12.000Z","date":"2020-03-19","kind":"exercise","acquired":true,"shares":35000,"price":5.42,"value":189700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares of common stock subject to restricted stock units (\"RSUs\") granted on June 10, 2019. The RSUs will fully vest on the earlier of (x) June 10, 2020 (the first anniversary of the date of grant) or (y) the day prior to Issuer's 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such dates."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-20-020483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/doc4.xml","form_type":"4"}},{"id":3203337,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-03-19T01:09:23.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was immediately exercisable for all option shares, but shares purchased under the option were subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vested in monthly installments upon completion of each month of Board service over a three year period measured from the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":5.42,"expiration_date":"2020-03-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-020143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/doc4.xml","form_type":"4"}},{"id":3203336,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T01:09:23.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":15000,"price":6.0174,"value":90261.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold at prices ranging from $6.00 to $6.20 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-020143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/doc4.xml","form_type":"4"}},{"id":3203335,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T01:09:23.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":15000,"price":5.42,"value":81300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares of common stock subject to restricted stock units (\"RSUs\") granted on June 10, 2019. The RSUs will fully vest on the earlier of (x) June 10, 2020 (the first anniversary of the date of grant) or (y) the day prior to Issuer's 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such dates."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-020143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/doc4.xml","form_type":"4"}},{"id":3493221,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-12T21:06:38.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer. The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":9.38,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-036440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119036440/doc4.xml","form_type":"4"}},{"id":3493220,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-12T21:06:38.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\"). The RSUs will fully vest on the earlier of (x) June 10, 2020 (the first anniversary of the date of grant) or (y) the day prior to the 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-036440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919119036440/doc4.xml","form_type":"4"}},{"id":3895088,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-13T20:06:33.000Z","date":"2018-06-11","kind":"exercise","acquired":false,"shares":29457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":295942,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":29457},"source":{"system":"sec-edgar","filing":"0000899243-18-016350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318016350/doc4.xml","form_type":"4"}},{"id":3895087,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-13T20:06:33.000Z","date":"2018-06-11","kind":"sale","acquired":false,"shares":29457,"price":30.8348,"value":908300.7036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $30.51 to $31.18, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-016350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318016350/doc4.xml","form_type":"4"}},{"id":3895086,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-13T20:06:33.000Z","date":"2018-06-11","kind":"exercise","acquired":true,"shares":29457,"price":3.0221,"value":89021.9997,"ownership":{"direct":true},"balance_after":344765,"source":{"system":"sec-edgar","filing":"0000899243-18-016350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318016350/doc4.xml","form_type":"4"}},{"id":3897411,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T00:24:55.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's service on the Board of the Directors of the Issuer.  The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Board service over the 12-month period measured from the grant date."}],"balance_after":15000,"derivative":{"exercise_price":15.65,"expiration_date":"2028-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-037345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118037345/doc4.xml","form_type":"4"}},{"id":3897410,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T00:24:55.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of restricted stock units (\"RSUs\").  The RSUs will fully vest on the earlier of (x) June 11, 2019 (the first anniversary of the date of grant) or (y) the day prior to the 2019 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-18-037345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118037345/doc4.xml","form_type":"4"}},{"id":3899589,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":42106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":325399,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":42106},"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899588,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-07","kind":"exercise","acquired":false,"shares":32598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":367505,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":32598},"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899587,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":30465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":400103,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":30465},"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899586,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":42106,"price":30.6966,"value":1292511.0396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $30.22 to $31.03, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899585,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":42106,"price":3.0221,"value":127248.5426,"ownership":{"direct":true},"balance_after":357414,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899584,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":500,"price":31.58,"value":15790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899583,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-07","kind":"sale","acquired":false,"shares":32098,"price":30.9465,"value":993320.757,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $30.45 to $31.43, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315808,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899582,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-07","kind":"exercise","acquired":true,"shares":32598,"price":3.0221,"value":98514.4158,"ownership":{"direct":true},"balance_after":347906,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899581,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":30465,"price":31.1955,"value":950370.9075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $30.68 to $31.55, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3899580,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-08T21:50:29.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":30465,"price":3.0221,"value":92068.2765,"ownership":{"direct":true},"balance_after":345773,"source":{"system":"sec-edgar","filing":"0000899243-18-015796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015796/doc4.xml","form_type":"4"}},{"id":3904557,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option(right to buy)","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":38825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":430568,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":38825},"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904556,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option(right to buy)","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-04","kind":"exercise","acquired":false,"shares":65352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":469393,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":65352},"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904555,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option(right to buy)","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":61197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option is immediately exercisable in full or in part.  The shares vest pursuant to the following schedule:  One forty-eighth (1/48th) of the shares subject to the option vest in 48 successive, equal monthly installments measured from May 13, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":534745,"derivative":{"exercise_price":3.0221,"expiration_date":"2025-05-18","underlying":"Common Stock","underlying_shares":61197},"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904554,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":38825,"price":31.8309,"value":1235834.6925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The transaction was executed in multiple trades in prices ranging from $31.55 to 32.36, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904553,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":38825,"price":3.0221,"value":117333.0325,"ownership":{"direct":true},"balance_after":354133,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904552,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":2612,"price":32.741,"value":85519.492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The transaction was executed in multiple trades in prices ranging from $32.58 to $32.80, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904551,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":62740,"price":31.8431,"value":1997836.094,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades in prices ranging from $31.45 to $32.33, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":317920,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904550,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-04","kind":"exercise","acquired":true,"shares":65352,"price":3.0221,"value":197500.2792,"ownership":{"direct":true},"balance_after":380660,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904549,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":2498,"price":33.186,"value":82898.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades in prices ranging from $33.13 to $33.20, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904548,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":58699,"price":32.5916,"value":1913094.3284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $32.06 to $33.06, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":317806,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904547,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":61197,"price":3.0221,"value":184943.4537,"ownership":{"direct":true},"balance_after":376505,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904546,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2017-10-12","kind":"gift","acquired":true,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2016 Grantor Retained Annuity Trust dated August 12, 2016 (the \"Second Mullens Trust\").  Such shares were transferred from the Second Mullens Trust to the Family Trust on October 12, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Family Trust.  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Family Trust."}],"balance_after":25532,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904545,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2017-10-12","kind":"gift","acquired":false,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife's GRAT 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2016 Grantor Retained Annuity Trust dated August 12, 2016 (the \"Second Mullens Trust\").  Such shares were transferred from the Second Mullens Trust to the Family Trust on October 12, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by the Second Mullens Trust.  Ms. Mullens has sole voting, investment and dispositive power over the shares held by the Second Mullens Trust.  Dr. Dilly disclaims beneficial ownership of the shares held by the Second Mullens Trust."}],"balance_after":12009,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904544,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2017-10-12","kind":"gift","acquired":true,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2016 Grantor Retained Annuity Trust dated August 12, 2016 (the \"Second Dilly Trust\").  Such shares were transferred from the Second Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Dilly Family Trust dated October 9, 2002 (the \"Family Trust\") on October 12, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Family Trust.  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Family Trust."}],"balance_after":23094,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":3904543,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-06-05T23:20:29.000Z","date":"2017-10-12","kind":"gift","acquired":false,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2016 Grantor Retained Annuity Trust dated August 12, 2016 (the \"Second Dilly Trust\").  Such shares were transferred from the Second Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Dilly Family Trust dated October 9, 2002 (the \"Family Trust\") on October 12, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the Second Dilly Trust.  Dr. Dilly has sole voting, investment and dispositive power over the shares held by the Second Dilly Trust."}],"balance_after":12009,"source":{"system":"sec-edgar","filing":"0000899243-18-015156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924318015156/doc4.xml","form_type":"4"}},{"id":4180547,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-25T20:05:32.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":100,"price":36.55,"value":3655.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":315308,"source":{"system":"sec-edgar","filing":"0000899243-17-024684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317024684/doc4.xml","form_type":"4"}},{"id":4180546,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-25T20:05:32.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":6960,"price":35.3921,"value":246329.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $34.79 to $35.61, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":315408,"source":{"system":"sec-edgar","filing":"0000899243-17-024684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317024684/doc4.xml","form_type":"4"}},{"id":4180545,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-25T20:05:32.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":17472,"price":34.1509,"value":596684.5248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $33.79 to $34.77, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":322368,"source":{"system":"sec-edgar","filing":"0000899243-17-024684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317024684/doc4.xml","form_type":"4"}},{"id":4180544,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-25T20:05:32.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":75468,"price":33.2309,"value":2507869.5612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $32.79 to $33.78, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":339840,"source":{"system":"sec-edgar","filing":"0000899243-17-024684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317024684/doc4.xml","form_type":"4"}},{"id":4183527,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-18T23:59:18.000Z","date":"2017-10-16","kind":"sale","acquired":false,"shares":1154,"price":26.238,"value":30278.652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $26.23 to $26.29, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":415308,"source":{"system":"sec-edgar","filing":"0000899243-17-024448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317024448/doc4.xml","form_type":"4"}},{"id":4190118,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-06T22:02:51.000Z","date":"2017-10-06","kind":"sale","acquired":false,"shares":4047,"price":26.308,"value":106468.476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $26.23 to $26.44, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":416462,"source":{"system":"sec-edgar","filing":"0000899243-17-023786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317023786/doc4.xml","form_type":"4"}},{"id":4190117,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-06T22:02:51.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":14689,"price":26.2438,"value":385495.1782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $26.23 to $26.29, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":420509,"source":{"system":"sec-edgar","filing":"0000899243-17-023786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317023786/doc4.xml","form_type":"4"}},{"id":4190116,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-06T22:02:51.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":30110,"price":26.2575,"value":790613.325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $26.23 to $26.29, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":435198,"source":{"system":"sec-edgar","filing":"0000899243-17-023786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317023786/doc4.xml","form_type":"4"}},{"id":4190115,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-10-06T22:02:51.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":50000,"price":26.2148,"value":1310740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $26.10 to $26.29, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":465308,"source":{"system":"sec-edgar","filing":"0000899243-17-023786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317023786/doc4.xml","form_type":"4"}},{"id":4200690,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-09-25","kind":"sale","acquired":false,"shares":100000,"price":25.0079,"value":2500790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This sale was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades in prices ranging from $24.90 to $25.33, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F10","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":515308,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200689,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":true,"shares":10328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Mullens Trust\").  Such shares were transferred from the First Mullens Trust to Edwina Lynette  Mullens and Stephen G. Dilly as Trustees of The Harriet F.L. Dilly 2015 Revocable Trust dated June 23, 2015 (the \"Harriet F.L. Dilly Trust\") on August 23, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Dilly Family Trust dated October 9, 2002 (the \"Family Trust\").  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Family Trust."}],"balance_after":20656,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200688,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":10328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife's GRAT 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Mullens Trust\").  Such shares were transferred from the First Mullens Trust to Edwina Lynette  Mullens and Stephen G. Dilly as Trustees of The Harriet F.L. Dilly 2015 Revocable Trust dated June 23, 2015 (the \"Harriet F.L. Dilly Trust\") on August 23, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the First Mullens Trust.  Ms. Mullens has sole voting, investment and dispositive power over the shares held by the First Mullens Trust.  Dr. Dilly disclaims beneficial ownership of the shares held by the First Mullens Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200687,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":true,"shares":41075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child's Trust 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Mullens Trust\").  Such shares were transferred from the First Mullens Trust to Edwina Lynette  Mullens and Stephen G. Dilly as Trustees of The Harriet F.L. Dilly 2015 Revocable Trust dated June 23, 2015 (the \"Harriet F.L. Dilly Trust\") on August 23, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held by the Harriet F.L. Dilly Trust.  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Frederick S W Dilly Trust."}],"balance_after":41075,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200686,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":41075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife's GRAT 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Mullens Trust\").  Such shares were transferred from the First Mullens Trust to Edwina Lynette  Mullens and Stephen G. Dilly as Trustees of The Harriet F.L. Dilly 2015 Revocable Trust dated June 23, 2015 (the \"Harriet F.L. Dilly Trust\") on August 23, 2017.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the First Mullens Trust.  Ms. Mullens has sole voting, investment and dispositive power over the shares held by the First Mullens Trust.  Dr. Dilly disclaims beneficial ownership of the shares held by the First Mullens Trust."}],"balance_after":10328,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200685,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":true,"shares":10328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Dilly Trust\").  Such shares were transferred from the First Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Frederick S W Dilly 2015 Irrevocable Trust dated June 23, 2015 (the \"Frederick S W Dilly Trust\") on August 23, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Dilly Family Trust dated October 9, 2002 (the \"Family Trust\").  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Family Trust."}],"balance_after":10328,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200684,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":10328,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Dilly Trust\").  Such shares were transferred from the First Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Frederick S W Dilly 2015 Irrevocable Trust dated June 23, 2015 (the \"Frederick S W Dilly Trust\") on August 23, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the First Dilly Trust.  Dr. Dilly has sole voting, investment and dispositive power over the shares held by the First Dilly Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200683,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":true,"shares":41075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Child's Trust 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Dilly Trust\").  Such shares were transferred from the First Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Frederick S W Dilly 2015 Irrevocable Trust dated June 23, 2015 (the \"Frederick S W Dilly Trust\") on August 23, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by the Frederick S W Dilly Trust.  Dr. Dilly and Ms. Mullens have joint voting, investment and dispositive power over the shares held by the Frederick S W Dilly Trust."}],"balance_after":41075,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4200682,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-09-27T20:05:32.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":41075,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities previously held indirectly by Stephen G. Dilly, as Trustee of The Stephen G. Dilly 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Dilly Trust\").  Such shares were transferred from the First Dilly Trust to Stephen G. Dilly and Edwina Lynette Mullens as Trustees of The Frederick S W Dilly 2015 Irrevocable Trust dated June 23, 2015 (the \"Frederick S W Dilly Trust\") on August 23, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by the First Dilly Trust.  Dr. Dilly has sole voting, investment and dispositive power over the shares held by the First Dilly Trust."}],"balance_after":10328,"source":{"system":"sec-edgar","filing":"0000899243-17-022644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317022644/doc4.xml","form_type":"4"}},{"id":4249221,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-07-28T20:31:25.000Z","date":"2017-07-26","kind":"sale","acquired":false,"shares":50000,"price":21.4622,"value":1073110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $21.19 to $21.81, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":615308,"source":{"system":"sec-edgar","filing":"0000899243-17-019292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317019292/doc4.xml","form_type":"4"}},{"id":4271534,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-06-27T20:06:08.000Z","date":"2017-06-23","kind":"sale","acquired":false,"shares":49400,"price":20.2144,"value":998591.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $20.15 to $20.31, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":665308,"source":{"system":"sec-edgar","filing":"0000899243-17-017282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317017282/doc4.xml","form_type":"4"}},{"id":4290286,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-07T22:02:22.000Z","date":"2017-06-05","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vest in monthly installments upon completion of each month of Board service over a one year period."}],"balance_after":10000,"derivative":{"exercise_price":7.2,"expiration_date":"2027-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-17-024394","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117024394/doc1.xml","form_type":"4"}},{"id":4322288,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-12T20:07:25.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":600,"price":20.15,"value":12090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":714708,"source":{"system":"sec-edgar","filing":"0000899243-17-012977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317012977/doc4.xml","form_type":"4"}},{"id":4424110,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-24T23:38:41.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest and become exercisable as to one-forty-eighth (1/48th) of the total number of shares subject to the option in successive, equal monthly installments measured from February 24, 2017, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":240000,"derivative":{"exercise_price":19.63,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0000899243-17-005266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924317005266/doc4.xml","form_type":"4"}},{"id":4554670,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-11-11","kind":"sale","acquired":false,"shares":25000,"price":25,"value":625000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":715308,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554669,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-11-11","kind":"sale","acquired":false,"shares":23696,"price":25.0249,"value":592990.0304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The transaction was executed in multiple trades in prices ranging from $25.00 to $25.17, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":740308,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554668,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-11-10","kind":"sale","acquired":false,"shares":1304,"price":25,"value":32600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":764004,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554667,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-08-24","kind":"gift","acquired":true,"shares":14447,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife's GRAT 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"This transaction involved a gift of securities previously held directly by Edwina Lynette Mullens to Edwina Lynette Mullens, Trustee, The Edwina Lynette Mullens 2016 Grantor Retained Annuity Trust DTD August 12, 2016 (the \"Second Mullens Trust\").  Such shares were transferred from Reporting Person's wife to the Second Mullens Trust on August 24, 2016.  Dr. Dilly disclaims beneficial ownership of the shares held by the Second Mullens Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These shares are held by the Second Mullens Trust.  Ms. Mullens has sole voting, investment and dispositive power over the shares held by the Second Mullens Trust.  Dr. Dilly disclaims beneficial ownership of the shares held by the Second Mullens Trust."}],"balance_after":14447,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554666,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-08-24","kind":"gift","acquired":false,"shares":14447,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"This transaction involved a gift of securities previously held directly by Edwina Lynette Mullens to Edwina Lynette Mullens, Trustee, The Edwina Lynette Mullens 2016 Grantor Retained Annuity Trust DTD August 12, 2016 (the \"Second Mullens Trust\").  Such shares were transferred from Reporting Person's wife to the Second Mullens Trust on August 24, 2016.  Dr. Dilly disclaims beneficial ownership of the shares held by the Second Mullens Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554665,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-08-24","kind":"gift","acquired":true,"shares":14447,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GRAT 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction involved a gift of securities previously held directly by Stephen G. Dilly to Stephen G. Dilly, Trustee, The Stephen G. Dilly 2016 Grantor Retained Annuity Trust DTD August 12, 2016 (the \"Second Dilly Trust\").  Such shares were transferred from Reporting Person to the Second Dilly Trust on August 24, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held by the Second Dilly Trust.  Dr. Dilly has sole voting, investment and dispositive power over the shares held by the Second Dilly Trust."}],"balance_after":14447,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554664,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-08-24","kind":"gift","acquired":false,"shares":14447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction involved a gift of securities previously held directly by Stephen G. Dilly to Stephen G. Dilly, Trustee, The Stephen G. Dilly 2016 Grantor Retained Annuity Trust DTD August 12, 2016 (the \"Second Dilly Trust\").  Such shares were transferred from Reporting Person to the Second Dilly Trust on August 24, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."}],"balance_after":765308,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}},{"id":4554663,"issuer":{"id":145931,"kind":"organization","name":"Aimmune Therapeutics, Inc.","symbol":"AIMT"},"owners":[{"id":36739,"kind":"person","name":"DILLY STEPHEN GEORGE","position":1,"cik":"0001389147","reported_name":"DILLY STEPHEN GEORGE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-15T21:05:37.000Z","date":"2016-07-25","kind":"gift","acquired":false,"shares":14447,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Wife's GRAT 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction involved a gift of securities previously held indirectly by Edwina Lynette Mullens, as Trustee of The Edwina Lynette Mullens 2015 Grantor Retained Annuity Trust dated June 23, 2015 (the \"First Mullens Trust\").  Such shares were transferred from the First Mullens Trust to Reporting Person's wife on July 25, 2016.  Dr. Dilly disclaims beneficial ownership of the shares held by Ms. Mullens."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held by the First Mullens Trust.  Ms. Mullens has sole voting, investment and dispositive power over the shares held by the First Mullens Trust.  Dr. Dilly disclaims beneficial ownership of the shares held by the First Mullens Trust."}],"balance_after":51403,"source":{"system":"sec-edgar","filing":"0000899243-16-033506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1389147/000089924316033506/doc4.xml","form_type":"4"}}],"next_cursor":"2016-11-15T21:05:37.000000Z,4554663"}